The Annals of Pharmacotherapy. 2009;43(3):519-527.

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

Its existing asthma and COPD franchise is made up of Pulmicort (which earned $867million ... drugs and drug combinations delivered via dry powder inhaler and metered dose inhaler devices.

Despite these benefits, inhalation drug delivery systems are still in the developmental stage, particularly for targeted local delivery. Dry powder inhalers (DPIs) have emerged as a popular choice due ...

Meanwhile, Pharmac's decision to fund the budesonide, glycopyrronium and formoterol aerosol inhaler is expected to help 5000 New Zealanders with COPD in the first year of funding, rising to 16,000 ...

Such patients require increasingly frequent courses of oral corticosteroids, often culminating in their long term use. Until recently in the UK, budesonide (Pulmicort Respules, Astra Pharmaceuticals) ...